CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older

-
BlogOn September 5, the Centers for Disease Control and Prevention endorsed the Advisory Committee on Immunization Practices’ recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31.CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
-
Blog
CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES
- CDC COVID-19 booster tool
- The County Role in Vaccines
- CDC Approves COVID-19 Vaccine for Children under 5
On September 5, the Centers for Disease Control and Prevention endorsed the Advisory Committee on Immunization Practices’ recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31.2022-09-08Blog2022-09-08
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES

About Blaire Bryant (Full Bio)
Legislative Director – Health | Large Urban County Caucus
More from Blaire Bryant
-
Reports & Toolkits
Legislative Analysis for Counties: The Inflation Reduction Act
The IRA offers counties the opportunity to pursue clean energy initiatives and reduce emissions through new competitive grant programs, local resiliency investments and clean energy tax credits. -
Press Release
National Association of Counties Announces Commission on Mental Health and Wellbeing
New initiative brings together county leaders to drive action on nation’s mental health crisis -
Reports & Toolkits
Medicaid and Counties: Understanding the Program and Why It Matters to Counties
As Congress considers changes to the nation’s health care system, NACo urges them to consider implications of reforms that would merely shift costs to counties. -
Reports & Toolkits
Behavioral Health Matters to Counties
Through 750 behavioral health authorities and community providers, county governments plan and operate community-based services for persons with mental illnesses and substance use conditions. -
Video
NACo Summit on Mental Health Solutions
Congressional, federal agency leaders and national thought leaders will gather with county officials to discuss priorities for curbing the ongoing mental health crisis. -
Webinar
Local Strategies for Reaching Families and Young Children Experiencing Homelessness
Feb. 8, 2023 , 2:00 pm – 3:00 pmUnable to attend? Watch the recording here.
Contact
-
Legislative Director – Health | Large Urban County Caucus(202) 942-4246
-
Legislative Assistant(202) 942-4259
Related Posts
-
BlogHHS awards CCBHC planning grants to 15 states to help address ongoing mental health crisisMar. 29, 2023
-
County NewsMaryland rural health program aims to prevent teen pregnancies, STIsMar. 27, 2023
-
BlogNACo submits comments to Senate HELP Committee on health care workforce shortagesMar. 23, 2023
Related Resources
-
Reports & ToolkitsMental Health Awareness Month: County Participation ToolkitMar. 24, 2023
-
DocumentThe Principles Quick Guide to Conducting a Needs AssessmentFeb. 27, 2023
-
Reports & ToolkitsThe County Role In Long-Term CareFeb. 24, 2023
Related Events
-
5Apr2023Webinar
County Leaders Championing Justice Efforts in Local Communities
Apr. 5, 2023 , 2:00 pm – 3:00 pm -
19Apr2023Webinar
Strategies for Leveraging County Health Rankings Data to Improve Community Health
Apr. 19, 2023 , 2:00 pm – 3:00 pm
More From
-
Opioid Solutions Center
NACo’s Opioid Solutions Center empowers local leaders to invest resources in effective treatment, recovery, prevention and harm reduction practices that save lives and address the underlying causes of substance use disorder.
Learn More